Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

How transparent were the COVID vaccine trials?

Daniel Hopkins, MD
Conditions
January 10, 2021
Share
Tweet
Share

On March 2nd, 2020, as New York State announced its first proven case of COVID-19, a federal court there handed down a stunning decision. For 10 years, according to the court, the United States government illegally failed to hold drug companies accountable when they did not report, or inaccurately reported, crucial data about their drugs’ safety and efficacy.

Between 2007 and 2017, the court held, the Food and Drug Administration knew of instances from roughly 1,000 drug trials in which manufacturers hid or misrepresented data. According to legislation passed in 1997, the FDA must publicly report such breaches. But to this day, they have not.

One week later, Donald Trump announced COVID-19 was “very much under control,” safer than the flu, and cases would soon be zero. We learned that the government would shrug its shoulders just as brazenly with COVID-19 as it had with drug company deceit. The federal government would become a stone-faced observer for the country’s most dire national disaster in a century, a failure that quickly eclipsed perhaps the most important legal decision on public health in a century. But it all comes full circle, eventually.

Millions of lives now depend on companies’ transparency that have spent decades hiding and distorting their scientific data. Pfizer, Moderna, AstraZeneca, and other drugmakers were put in charge of the best short-term option the world has for stanching the flow from a biblical pestilence that has killed hundreds of thousands of Americans and millions more globally (so far).

In public statements more befitting an SNL cold open, or perhaps an Onion headline, the drug companies have repeatedly promised to be transparent and ethical in developing, testing, and distributing COVID vaccines. But these are not just old dogs claiming to learn a new trick. These are morbidly obese, henhouse foxes with a Cheshire grin and a golden toothpick in their teeth.

Dr. Peter Doshi, a health services researcher and editor at the British Medical Journal, is familiar with that grin. Doshi examined hundreds of thousands of pages of study reports dumped on his head by spiteful drug companies forced into “transparency” by public outrage when it was discovered they hid and misrepresented data on Tamiflu years ago. The pricey blockbuster drug, stockpiled by governments as a bioterrorism remedy and commonly used worldwide as a “cure” for the flu, is no better than a dose of ibuprofen at the local pharmacy. This we learned from Doshi, Tom Jefferson, and others who gave years of their lives sifting through the data.

Now, Doshi, a default transparency watchdog for the drug industry, has published what amounts to a transparency challenge for Pfizer, Moderna, and other vaccine makers. After reviewing published data this week, he reports on a number of gaping holes in the vaccine data, holes that need to be filled if the company claims their vaccines are considered credible.

Most prominent and most concerning, is the absence of data first reported weeks ago by editors at TheNNT.com, an open access, physician-run website for health care evidence reviews. Doshi confirms: FDA documents show in Pfizer’s vaccine trial thousands of patients experienced “suspected but unconfirmed” COVID-19, with no mention of who was tested, or how many. Were suspected cases all tested, as the study protocol calls for? Were they tested equally in vaccine and placebo groups? With just 170 cases of COVID-19 reported in the trial, but more than 3000 suspected cases, any imbalance in testing between groups could easily affect—or even reverse—the trial’s results.

Doshi also points to 371 study subjects mysteriously “excluded” from Pfizer’s analysis and the potential effects of unblinding caused by vaccine injection side effects. His points are valid and crucial, each representing potentially game-changing results from the trial—and each could be resolved with access to the raw trial data.

So how about it, Pfizer? And Moderna? Is genuine transparency something you can do? In the modern world’s moment of greatest humanitarian crisis, can you open the books? Or have decades of hiding and distorting hardened you? Can you show us you’re willing to play fair?

If only we had a government of the people, instead of above the people. This would be a snap.

Daniel Hopkins is a physician.

Image credit: Shutterstock.com 

ADVERTISEMENT

Prev

When an epidemic of violence against health care workers meets a pandemic [PODCAST]

January 9, 2021 Kevin 0
…
Next

Why do I laugh during a pandemic?

January 10, 2021 Kevin 3
…

Tagged as: COVID, Infectious Disease

Post navigation

< Previous Post
When an epidemic of violence against health care workers meets a pandemic [PODCAST]
Next Post >
Why do I laugh during a pandemic?

ADVERTISEMENT

More by Daniel Hopkins, MD

  • A physician questions the COVID vaccine data from Israel

    Daniel Hopkins, MD
  • Enthusiasm over evidence? What the Israeli vaccination data actually show.

    Daniel Hopkins, MD
  • Why remdesivir may not be a wonder drug

    Daniel Hopkins, MD

Related Posts

  • Major medical groups back mandatory COVID vaccine for health care workers

    Molly Walker
  • Is it time for a true federal COVID vaccine mandate?

    Shetal Shah, MD
  • The COVID vaccine selfie: The caption matters as much as the picture

    Alicia Billington, MD, PhD
  • COVID-19 divides and conquers

    Michele Luckenbaugh
  • Where’s the big COVID data?

    Anuradha Kolluru, MD and Rakesh Lattupalli, MD
  • COVID-19 vaccine and disinformation: How health care providers can leverage social media to combat this trend

    Emmanuel Ohuabunwa, MD, MBA, Victor Agbafe, and Onyema Ogbuagu, MD

More in Conditions

  • How one unforgettable ER patient taught a nurse about resilience

    Kristen Cline, BSN, RN
  • Why regular exercise is the best prescription for lifelong health

    George F. Smith, MD
  • When the weight won’t budge: the hidden physiology of grief, stress, and set point

    Sarah White, APRN
  • Why peer support can save lives in high-pressure medical careers

    Maire Daugharty, MD
  • Addressing menstrual health inequities in adolescents

    Callia Georgoulis
  • Healing beyond the surface: Why proper chronic wound care matters

    Alvin May, MD
  • Most Popular

  • Past Week

    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • Why specialist pain clinics and addiction treatment services require strong primary care

      Olumuyiwa Bamgbade, MD | Conditions
    • Harassment and overreach are driving physicians to quit

      Olumuyiwa Bamgbade, MD | Physician
    • Why peer support can save lives in high-pressure medical careers

      Maire Daugharty, MD | Conditions
    • When a medical office sublease turns into a legal nightmare

      Ralph Messo, DO | Physician
    • Addressing menstrual health inequities in adolescents

      Callia Georgoulis | Conditions
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • The physician who turned burnout into a mission for change

      Jessie Mahoney, MD | Physician
    • Time theft: the unseen harm of abusive oversight

      Kayvan Haddadan, MD | Physician
    • How one unforgettable ER patient taught a nurse about resilience

      Kristen Cline, BSN, RN | Conditions
    • The future of clinical care: AI’s role in easing physician workload

      Michael Wakeman | Tech
    • Eric Topol explores the science of super-agers and healthy aging [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why more doctors are leaving clinical practice and how it helps health care

      Arlen Meyers, MD, MBA | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • Why specialist pain clinics and addiction treatment services require strong primary care

      Olumuyiwa Bamgbade, MD | Conditions
    • Harassment and overreach are driving physicians to quit

      Olumuyiwa Bamgbade, MD | Physician
    • Why peer support can save lives in high-pressure medical careers

      Maire Daugharty, MD | Conditions
    • When a medical office sublease turns into a legal nightmare

      Ralph Messo, DO | Physician
    • Addressing menstrual health inequities in adolescents

      Callia Georgoulis | Conditions
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Who gets to be well in America: Immigrant health is on the line

      Joshua Vasquez, MD | Policy
    • Here’s what providers really need in a modern EHR

      Laura Kohlhagen, MD, MBA | Tech
  • Recent Posts

    • The physician who turned burnout into a mission for change

      Jessie Mahoney, MD | Physician
    • Time theft: the unseen harm of abusive oversight

      Kayvan Haddadan, MD | Physician
    • How one unforgettable ER patient taught a nurse about resilience

      Kristen Cline, BSN, RN | Conditions
    • The future of clinical care: AI’s role in easing physician workload

      Michael Wakeman | Tech
    • Eric Topol explores the science of super-agers and healthy aging [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why more doctors are leaving clinical practice and how it helps health care

      Arlen Meyers, MD, MBA | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

How transparent were the COVID vaccine trials?
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...